Table of Contents
Global Orphan Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Biologics -Product Introduction and Major Manufacturers
1.1.2 Non-Biologics -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Orphan Drug Status and Prospect (2015-2026)
2.1.1 China Orphan Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Orphan Drug Status and Prospect (2015-2026)
2.2.1 EU Orphan Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Orphan Drug Status and Prospect (2015-2026)
2.3.1 USA Orphan Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Orphan Drug Status and Prospect (2015-2026)
2.4.1 Japan Orphan Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Orphan Drug Status and Prospect (2015-2026)
2.5.1 India Orphan Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Orphan Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Orphan Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Orphan Drug Status and Prospect (2015-2026)
2.7.1 South America Orphan Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Orphan Drug Status and Prospect (2015-2026)
2.8.1 Orphan Drug Market Size and Growth Rate (2015-2026)
2.8.2 Orphan Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Orphan Drug Market Assessment by Segment
3.1 Global Orphan Drug Capacity and Growth Rate
3.2 Global Orphan Drug Sales by Type
3.3 Global Orphan Drug Sales Revenue by Type
3.4 Global Orphan Drug Consumption by Application
4 Global Orphan Drug Market Assessment by Regions
4.1 Global Orphan Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Orphan Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Orphan Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Orphan Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Orphan Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Orphan Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Orphan Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Orphan Drug Sales Revenue Market Share of Manufacturers (2019-2020)
7 Orphan Drug Competitive Analysis
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Profiles
7.1.2 AbbVie Inc. Product Introduction
7.1.3 AbbVie Inc. Orphan Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Aegerion Pharmaceuticals, Inc.
7.2.1 Aegerion Pharmaceuticals, Inc. Company Profiles
7.2.2 Aegerion Pharmaceuticals, Inc. Product Introduction
7.2.3 Aegerion Pharmaceuticals, Inc. Orphan Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Profiles
7.3.2 Bristol-Myers Squibb Company Product Introduction
7.3.3 Bristol-Myers Squibb Company Orphan Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Celgene Corporation
7.4.1 Celgene Corporation Company Profiles
7.4.2 Celgene Corporation Product Introduction
7.4.3 Celgene Corporation Orphan Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Profiles
7.5.2 F. Hoffmann-La Roche Ltd. Product Introduction
7.5.3 F. Hoffmann-La Roche Ltd. Orphan Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Company Profiles
7.6.2 GlaxoSmithKline plc Product Introduction
7.6.3 GlaxoSmithKline plc Orphan Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Profiles
7.7.2 Johnson & Johnson Product Introduction
7.7.3 Johnson & Johnson Orphan Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Novartis AG
7.8.1 Novartis AG Company Profiles
7.8.2 Novartis AG Product Introduction
7.8.3 Novartis AG Orphan Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Profiles
7.9.2 Pfizer Inc. Product Introduction
7.9.3 Pfizer Inc. Orphan Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Sanofi
7.10.1 Sanofi Company Profiles
7.10.2 Sanofi Product Introduction
7.10.3 Sanofi Orphan Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
8 Conclusion
List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Orphan Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Orphan Drug Sales (K Unit) by Type (2015-2026)
Figure Global Orphan Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Orphan Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Orphan Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Orphan Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Orphan Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Orphan Drug Sales (K Unit) by Application (2015-2026)
Figure China Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table China Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table India Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Orphan Drug Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Orphan Drug Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Orphan Drug Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Orphan Drug Capacity (K Units) and Growth Rate (2015-2026)
Table Global Orphan Drug Sales (Unit) by Type (2015-2026)
Figure Global Orphan Drug Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Orphan Drug Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Orphan Drug Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Orphan Drug Consumption (Unit) by Application (2015-2026)
Figure Global Orphan Drug Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Orphan Drug Production (K Unite) by Regions (2015-2020)
Table Global Orphan Drug CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Orphan Drug Production Share by Regions (2019-2020)
Table Global Orphan Drug Sales (K Unite) by Regions (2015-2020)
Table Global Orphan Drug CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Orphan Drug Sales Share by Regions (2019-2020)
Table Global Orphan Drug Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Orphan Drug CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Orphan Drug Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Orphan Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Orphan Drug
Figure Cost Structure of Orphan Drug in 2020
Table Global Orphan Drug Capacity Share of Manufacturers (2019-2020)
Figure Global Orphan Drug Capacity Share of Manufacturers (2019-2020)
Table Global Orphan Drug Sales Market Share of Manufacturers (2019-2020)
Figure Global Orphan Drug Sales Market Share of Manufacturers (2019-2020)
Table Global Orphan Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Orphan Drug Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Orphan Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table AbbVie Inc. Profiles
Table AbbVie Inc. Orphan Drug Product Introduction
Table AbbVie Inc. Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure AbbVie Inc. SWOT Analysis
Table Aegerion Pharmaceuticals, Inc. Profiles
Table Aegerion Pharmaceuticals, Inc. Orphan Drug Product Introduction
Table Aegerion Pharmaceuticals, Inc. Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Aegerion Pharmaceuticals, Inc. SWOT Analysis
Table Bristol-Myers Squibb Company Profiles
Table Bristol-Myers Squibb Company Orphan Drug Product Introduction
Table Bristol-Myers Squibb Company Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Company SWOT Analysis
Table Celgene Corporation Profiles
Table Celgene Corporation Orphan Drug Product Introduction
Table Celgene Corporation Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Celgene Corporation SWOT Analysis
Table F. Hoffmann-La Roche Ltd. Profiles
Table F. Hoffmann-La Roche Ltd. Orphan Drug Product Introduction
Table F. Hoffmann-La Roche Ltd. Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure F. Hoffmann-La Roche Ltd. SWOT Analysis
Table GlaxoSmithKline plc Profiles
Table GlaxoSmithKline plc Orphan Drug Product Introduction
Table GlaxoSmithKline plc Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure GlaxoSmithKline plc SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Orphan Drug Product Introduction
Table Johnson & Johnson Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Johnson & Johnson SWOT Analysis
Table Novartis AG Profiles
Table Novartis AG Orphan Drug Product Introduction
Table Novartis AG Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Novartis AG SWOT Analysis
Table Pfizer Inc. Profiles
Table Pfizer Inc. Orphan Drug Product Introduction
Table Pfizer Inc. Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Pfizer Inc. SWOT Analysis
Table Sanofi Profiles
Table Sanofi Orphan Drug Product Introduction
Table Sanofi Orphan Drug Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Sanofi SWOT Analysis
Please ask for List of Figures. Request Sample Report